|
|
News Breaks | | | | February 19, 2013 | | 09:01 EDT |  | BPAX | Egan-Jones recommends investors vote for BioSante, ANI merger
BioSante Pharmaceuticals announced that Egan-Jones Proxy Services, an independent proxy advisory firm, has recommended that BioSante stockholders vote “FOR” the adoption of the merger agreement between BioSante and ANIP Acquisition Company d/b/a ANI Pharmaceuticals, Inc. and all related matters being submitted to a vote of BioSante stockholders at BioSante’s upcoming special meeting of stockholders scheduled to be held on March 15. In recommending that the merger transaction be approved, Egan-Jones noted, “Based on our review of publicly available information on strategic, corporate governance and financial aspects of the proposed transaction, Egan-Jones views the proposed transaction to be a desirable approach in maximizing shareholder value and recommends that clients holding shares of BioSante Pharmaceuticals, Inc. vote “FOR” this Proposal.” | |
|
News For BPAX From The Last 14 Days Check below for free stories on BPAX the last two weeks. |
|
|
| June 18, 2013 | | 13:24 EDT |  | BPAX | BioSante to host special shareholder meeting
 Subscribe for More Information | |
|
|
|
|
|
|
